Svarnadri Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 26-05-2024
- Paid Up Capital ₹ 0.50 M
as on 26-05-2024
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
About Svarnadri Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Mallarachappa Rudramunayappa and Manohar Mallarachappa serve as directors at the Company.
- CIN/LLPIN
U24230KA2021PTC146758
- Company No.
146758
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Svarnadri Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mallarachappa Rudramunayappa  | Director | 20-Apr-2021 | Current |
| Manohar Mallarachappa | Director | 20-Apr-2021 | Current |
Financial Performance of Svarnadri Pharmaceuticals.
Enhance accessibility to Svarnadri Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Svarnadri Pharmaceuticals?
Unlock access to Svarnadri Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Svarnadri Agri Impex Global Private LimitedActive 3 years 10 daysMallarachappa Rudramunayappa and Manohar Mallarachappa are mutual person
- Svarnadri Foods And Beverages Private LimitedActive 5 years 11 months
Mallarachappa Rudramunayappa and Manohar Mallarachappa are mutual person
- Svarnadri Chit Funds Private LimitedActive 7 years 11 months
Mallarachappa Rudramunayappa and Manohar Mallarachappa are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Svarnadri Pharmaceuticals?
Svarnadri Pharmaceuticals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Svarnadri Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Svarnadri Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
